APA (7th ed.) Citation

Perrot, A., Delimpasi, S., Spanoudakis, E., Frølund, U., Belotti, A., Oriol, A., . . . Dimopoulos, M. A. (2024). An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & Lymphoma, 65(6), 833. https://doi.org/10.1080/10428194.2024.2322030

Chicago Style (17th ed.) Citation

Perrot, Aurore, et al. "An Open-label Phase 2 Study Treating Patients with First or Second Relapse of Multiple Myeloma with Carfilzomib, Pomalidomide, and Dexamethasone (KPd): SELECT Study." Leukemia & Lymphoma 65, no. 6 (2024): 833. https://doi.org/10.1080/10428194.2024.2322030.

MLA (9th ed.) Citation

Perrot, Aurore, et al. "An Open-label Phase 2 Study Treating Patients with First or Second Relapse of Multiple Myeloma with Carfilzomib, Pomalidomide, and Dexamethasone (KPd): SELECT Study." Leukemia & Lymphoma, vol. 65, no. 6, 2024, p. 833, https://doi.org/10.1080/10428194.2024.2322030.